Akiyama Hironori, Furukawa Souhei, Wakisaka Satoshi, Maeda Takashi
Department of Anatomy and Cell Biology, Graduate School of Dentistry, Osaka University, 1-8 Yamadaoka, Suita, Osaka 565-0871, Japan.
Mol Cell Biochem. 2007 Oct;304(1-2):243-8. doi: 10.1007/s11010-007-9506-6. Epub 2007 May 30.
CTRP3/cartducin, a novel secretory protein, is a member of the C1q and tumor necrosis factor (TNF)-related protein (CTRP) superfamily. CTRP3/cartducin gene is transiently up-regulated in a balloon-injured rat carotid artery tissue. In this study, we report a new function of CTRP3/cartducin as a regulator of angiogenic processes. CTRP3/cartducin promoted proliferation and migration of mouse endothelial MSS31 cells in a dose-dependent manner. Further, stimulation of MSS31 by CTRP3/cartducin led to activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK). MAPK/ERK kinase 1/2 (MEK1/2) inhibitor, U0126, and p38 MAPK inhibitor, SB203580, blocked the CTRP3/cartducin-induced cell proliferation, and migration was blocked by U0126, but not the SB203580. Taken together, these results suggest that CTRP3/cartducin may be involved as a novel angiogenic factor in the formation of neointima following angioplasty.
CTRP3/cartducin是一种新型分泌蛋白,属于C1q和肿瘤坏死因子(TNF)相关蛋白(CTRP)超家族。CTRP3/cartducin基因在球囊损伤的大鼠颈动脉组织中短暂上调。在本研究中,我们报告了CTRP3/cartducin作为血管生成过程调节剂的新功能。CTRP3/cartducin以剂量依赖的方式促进小鼠内皮MSS31细胞的增殖和迁移。此外,CTRP3/cartducin对MSS31的刺激导致细胞外信号调节激酶1/2(ERK1/2)和p38丝裂原活化蛋白激酶(MAPK)的激活。MAPK/ERK激酶1/2(MEK1/2)抑制剂U0126和p38 MAPK抑制剂SB203580阻断了CTRP3/cartducin诱导的细胞增殖,U0126阻断了迁移,但SB203580没有。综上所述,这些结果表明CTRP3/cartducin可能作为一种新型血管生成因子参与血管成形术后新生内膜的形成。